|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Provision for credit losses | |||||
| Depreciation | |||||
| Accretion on loans | |||||
| Amortization of intangibles | |||||
| Amortization of subordinated notes issuance costs | |||||
| Deferred income tax provision (benefit) | |||||
| Charges on redemption of subordinated notes | |||||
| Investment securities losses | |||||
| Restricted stock expense | |||||
| Stock-based compensation | |||||
| Net amortization of investment premiums | |||||
| Earnings on bank owned life insurance | |||||
| Gain on bank owned life insurance proceeds | |||||
| Gain on sale of asset | |||||
| Net change in: | |||||
| Accrued interest receivable | |||||
| Other assets | |||||
| Other liabilities | |||||
| Net cash from operating activities | |||||
| Cash flows from/(used) investing activities | |||||
| Purchases of investment securities available-for-sale | |||||
| Proceeds from sale of investment securities available-for-sale | |||||
| Proceeds from paydowns of investment securities available-for-sale | |||||
| Proceeds from maturities and calls of investment securities available-for-sale | |||||
| Purchase of restricted investment in bank stocks | |||||
| Proceeds from redemptions of restricted investment in bank stocks | |||||
| Net decrease (increase) in loans | |||||
| Purchases of premises and equipment | |||||
| Disposal of premises and equipment | |||||
| Proceeds from sale of premises and equipment | |||||
| Proceeds from bank owned life insurance | |||||
| Net cash from/(used) by investing activities | |||||
| Cash flows from/(used) financing activities | |||||
| Net increase in deposits | |||||
| Net change in FHLB advances, short term | |||||
| Proceeds from FHLB advances, long term | |||||
| Redemption of subordinated notes | |||||
| Issuance of subordinated notes, net of issuance costs | |||||
| Capital raise, net of issuance costs | |||||
| Cash dividends paid | |||||
| Purchases of treasury stock | |||||
| Net cash from/(used) financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Beginning cash and cash equivalents | |||||
| Ending cash and cash equivalents | |||||
| Supplemental cash flow information: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Supplemental noncash disclosures: | |||||
| Lease liabilities arising from obtaining right-of-use assets | |||||
Loading...